Viehbacher Christopher
Insider CIK 1774478 · BRVE Director · BIIB President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-07 | 83,333 | $18.00 | $1.50M | 609,519 | SEC↗ |
| BRVE Braveheart Bio, Inc. | P Buy | 2026-08-07 | 2026-08-07 | 83,333 | $18.00 | $1.50M | 609,519 | SEC↗ |
| BRVE Braveheart Bio, Inc. | A Award deriv | 2026-08-05 | 2026-08-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BRVE Braveheart Bio, Inc. | A Award deriv | 2026-08-05 | 2026-08-07 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2026-02-13 | 2026-02-17 | 38,015 | — | $0 | 38,015 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2026-02-06 | 2026-02-10 | 15,453 | — | $0 | 30,907 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2026-02-06 | 2026-02-10 | 9,008 | — | $0 | 9,009 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2026-02-06 | 2026-02-10 | 4,356 | $201.18 | $876.3K | 21,095 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2026-02-06 | 2026-02-10 | 15,453 | — | $0 | 36,548 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2026-02-06 | 2026-02-10 | 6,624 | $201.18 | $1.33M | 29,924 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2026-02-06 | 2026-02-10 | 9,008 | — | $0 | 25,451 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2025-12-01 | 2025-12-03 | 7,040 | — | $0 | 0 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2025-12-01 | 2025-12-03 | 3,404 | $177.78 | $605.2K | 16,443 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2025-12-01 | 2025-12-03 | 7,040 | — | $0 | 19,847 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise deriv | 2025-02-07 | 2025-02-10 | 9,008 | — | $0 | 18,017 | SEC↗ |
| BIIB BIOGEN INC. | M Exercise | 2025-02-07 | 2025-02-10 | 9,008 | — | $0 | 16,008 | SEC↗ |
| BIIB BIOGEN INC. | F Tax w/h | 2025-02-07 | 2025-02-10 | 3,201 | $141.35 | $452.5K | 12,807 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2025-02-06 | 2025-02-10 | 46,360 | — | $0 | 46,360 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2024-02-07 | 2024-02-09 | 27,025 | — | $0 | 27,025 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2022-12-01 | 2022-12-05 | 7,040 | — | $0 | 7,040 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2022-12-01 | 2022-12-05 | 80,522 | — | $0 | 80,522 | SEC↗ |
| BIIB BIOGEN INC. | A Award deriv | 2022-12-01 | 2022-12-05 | 45,998 | — | $0 | 45,998 | SEC↗ |